RE:RE:RE:Multiple Myeloma In General and NCT03605719 Specifically@inthno. Thank you. I thought that was the case, and just now
checked myself.
I was looking at the presentation and MM has almost been purged with the exception of a small mention of BMS. I do not have a problem with the purge but find it a little curious. Anyway, I have been wondering for quite a while why we went after solid tumors with CAR T. I do now wonder if BMS would be interested in pela loaded CAR T and the after boost. ONC does not seem to say CAR T research going forward is limited to solid tumors.
I guess I am saying ONC seem to be playing their cards close to the vest.
A question from a lay person to you or Noteable; if a drug works in solid tumors, is it a given it will work in liquid tumors? Hypothetically.